Cargando…
Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer
BACKGROUND: Carbonic anhydrase 9 (CA9) is a marker for hypoxia and acidosis, which is linked to a poor prognosis in human tumors. The purpose of this comparative analysis was to evaluate whether CA9 and VEGF expression are associated with survival outcomes in patients with metastatic colorectal canc...
Autores principales: | Hong, Yong Sang, Cho, Hyeon Jin, Kim, Sun Young, Jung, Kyung Hae, Park, Ji Won, Choi, Hyo Seong, Oh, Jae Hwan, Kim, Byung Chang, Sohn, Dae Kyung, Kim, Dae Yong, Chang, Hee Jin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719665/ https://www.ncbi.nlm.nih.gov/pubmed/19619339 http://dx.doi.org/10.1186/1471-2407-9-246 |
Ejemplares similares
-
Granulomatous Inflammation and Pericarditis Induced by Silk Granuloma Related to Previous Surgical Ligation of Patent Ductus Arteriosus in a Dog
por: Moon, Chang-Hwan, et al.
Publicado: (2022) -
Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-Term Outcomes
por: Kim, Yong Sok, et al.
Publicado: (2016) -
Hemodynamic and Histopathologic Benefits of Early Treatment with Macitentan in a Rat Model of Pulmonary Arterial Hypertension
por: Kim, Kyung-Hee, et al.
Publicado: (2018) -
Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer
por: Han, Kyung Su, et al.
Publicado: (2016) -
Bevacizumab increases the risk of anastomosis site leakage in metastatic colorectal cancer
por: Kim, Seijong, et al.
Publicado: (2022)